Design Therapeutics (DSGN) Beats Q4 Earnings Estimates by $0.09
Design Therapeutics (NASDAQ:DSGN) reported quarterly earnings results on March 09, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
